Ideaya Biosciences Stock Forward View
| IDYA Stock | USD 32.83 -1.22 -3.58% |
Momentum
Impartial
Oversold | Overbought |
EPS Estimate Next Quarter -0.93 | EPS Estimate Current Year -3.93 | EPS Estimate Next Year -3.37 | Wall Street Target Price 50.0625 | EPS Estimate Current Quarter -0.95 |
This view frames how Ideaya Biosciences responds to recent headlines and peer activity within its market context. Sentiment is summarized using Ideaya Biosciences' options positioning and short interest activity.
Ideaya Biosciences Short Interest
A significant increase or decrease in Ideaya Biosciences' short interest from the previous month could be a good indicator of investor sentiment towards Ideaya. Short interest can provide insight into the potential direction of Ideaya Biosciences stock and how bullish or bearish investors.
200 Day MA 28.5663 | Short Percent 0.1307 | Short Ratio 11.49 | Shares Short Prior Month 10 M | 50 Day MA 33.9164 |
Ideaya Relative Strength Index
The Naive Prediction forecasted value of Ideaya Biosciences on the next trading day is expected to be 32.60 with a mean absolute deviation of 0.65 and the sum of the absolute errors of 39.78.Ideaya Biosciences Hype to Price Pattern
Investor biases related to Ideaya Biosciences' public news can be used to forecast risks associated with an investment in Ideaya. The trend in average sentiment can be used to explain how an investor holding Ideaya can time the market purely based on public headlines and social.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Ideaya Biosciences' market sentiment to its price can help traders make decisions based on the overall investor consensus about Ideaya Biosciences.
Ideaya Biosciences Implied Volatility | 2.02 |
Ideaya Biosciences' implied volatility exposes the market's sentiment of Ideaya Biosciences stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Ideaya Biosciences' implied volatility is high, the market thinks the stock has potential.
The Naive Prediction forecasted value of Ideaya Biosciences on the next trading day is expected to be 32.60 with a mean absolute deviation of 0.65 and the sum of the absolute errors of 39.78.Ideaya Biosciences after-hype prediction price | $ 32.83 |
Sentiment indicators are one input among forecasting models, technical signals, analyst estimates, earnings data, and momentum measures.
Use Historical Fundamental Analysis of Ideaya Biosciences to cross-verify projections for Ideaya Biosciences. The view provides historical context for the projection set.Rule 16 for the current Ideaya contract - Volatility Context
Using the Rule 16 heuristic, the current implied volatility suggests an average daily move of about 0.13% for the 2026-04-17 options. With Ideaya Biosciences trading near $ 32.83, that translates to about $ 0.0414 per day in either direction.
Open Interest for Ideaya 2026-04-17 Options
Open interest counts active option contracts on Ideaya Biosciences, providing a view of participation and positioning in the options market. It adds context to volatility and price behavior.
Ideaya Biosciences Additional Predictive Modules
Most predictive techniques to examine Ideaya price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Ideaya using various technical indicators. When you analyze Ideaya charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Ideaya Biosciences Cash Forecast
Forecasting cash, or other financial indicators, requires analysts to apply different statistical methods, techniques, and algorithms to find hidden patterns within the Ideaya Biosciences' financial statements to predict how it will affect future prices.
Cash | First Reported 2018-03-31 | Previous Quarter 298.9 M | Current Value 112.8 M | Quarterly Volatility 81.1 M |
Macro event markers
Naive Prediction Price Forecast For the 14th of March 2026
Given 90 days horizon, the Naive Prediction forecasted value of Ideaya Biosciences on the next trading day is expected to be 32.60 with a mean absolute deviation of 0.65 , mean absolute percentage error of 0.64 , and the sum of the absolute errors of 39.78 .Please note that although there have been many attempts to predict Ideaya Stock prices using its time series forecasting, we generally do not suggest using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Ideaya Biosciences' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Stock Forecast Pattern
| Backtest Ideaya Biosciences | Ideaya Biosciences Price Prediction | Research Analysis |
Forecasted Value
This next-day forecast for Ideaya Biosciences uses model performance to estimate practical downside and upside boundaries rather than a single point target alone. Investors should still remember that no empirical framework consistently proves that one family of forecasting models will outperform all other approaches in live markets.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of Ideaya Biosciences stock data series using in forecasting. Note that when a statistical model is used to represent Ideaya Biosciences stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 117.6632 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 0.6521 |
| MAPE | Mean absolute percentage error | 0.0192 |
| SAE | Sum of the absolute errors | 39.7782 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Ideaya Biosciences' price to converge to an average value over time is called mean reversion.
After-Hype Price Density Analysis
As far as predicting the price of Ideaya Biosciences at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range.
Next price density |
| Expected price to next headline |
Estimiated After-Hype Price Volatility
In the context of predicting Ideaya Biosciences' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Ideaya Biosciences' historical news coverage.
Current Value
The after-hype framework applied to Ideaya Biosciences assumes a 3 months review window and focuses on post-sentiment normalization rather than raw momentum. This view is most useful when investors want to compare sentiment-driven price extension with a more measured post-news scenario.
Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Ideaya Biosciences is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Ideaya Biosciences backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Ideaya Biosciences, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.01 | 2.79 | 0.00 | 0.00 | 9 Events | 7 Events | In 9 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
32.83 | 32.83 | 0.00 |
|
Hype Timeline
Ideaya Biosciences is currently traded for 32.83. The company stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Ideaya is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over 100%. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is currently at 0.01%. %. The volatility of related hype on Ideaya Biosciences is about 1279.82%, with the expected price after the next announcement by competition of 32.83. About 98.0% of the company shares are owned by institutional investors. The book value of Ideaya Biosciences was currently reported as 11.65. The company recorded a loss per share of 1.28. Ideaya Biosciences had not issued any dividends in recent years. Given the investment horizon of 90 days the next forecasted press release will be in 9 days. Use Historical Fundamental Analysis of Ideaya Biosciences to cross-verify projections for Ideaya Biosciences. The view provides historical context for the projection set.Related Hype Analysis
Having access to credible news sources related to Ideaya Biosciences' direct competition is more important than ever and may enhance your ability to predict Ideaya Biosciences' future price movements. Getting to know how Ideaya Biosciences' peers react to changing market sentiment, related social.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| SRRK | Scholar Rock Holding | -0.98 | 11 per month | 0.00 | -0.01 | 5.12 | -4.53 | 14.33 | |
| MLYS | Mineralys Therapeutics Common | 0.09 | 9 per month | 0.00 | -0.14 | 4.37 | -6.28 | 17.36 | |
| ZLAB | Zai Lab | 0.89 | 9 per month | 0.00 | 0.01 | 6.02 | -3.77 | 10.90 | |
| CDTX | Cidara Therapeutics | 0.33 | 2 per month | 1.30 | 0.14 | 5.93 | -4.54 | 105.72 | |
| BEAM | Beam Therapeutics | -3.39 | 7 per month | 3.88 | 0.01 | 7.24 | -7.88 | 31.78 | |
| ADPT | Adaptive Biotechnologies Corp | 0.54 | 9 per month | 0.00 | -0.04 | 4.29 | -5.30 | 22.58 | |
| FOLD | Amicus Therapeutics | -0.02 | 11 per month | 0.00 | 0.17 | 1.01 | -0.49 | 30.77 | |
| KNSA | Kiniksa Pharmaceuticals | 0.41 | 15 per month | 2.50 | 0.09 | 3.93 | -3.63 | 12.32 | |
| LEGN | Legend Biotech Corp | -0.51 | 10 per month | 0.00 | -0.13 | 5.78 | -6.84 | 19.65 | |
| COGT | Cogent Biosciences | 0.46 | 9 per month | 0.00 | -0.02 | 5.17 | -4.39 | 14.32 |
Other Forecasting Options for Ideaya Biosciences
For every potential investor in Ideaya, whether a beginner or expert, Ideaya Biosciences' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better.Ideaya Biosciences Related Equities
The following equities are related to Ideaya Biosciences within the Health Care space and can be used for peer comparison, relative valuation, or portfolio diversification. Comparing Ideaya Biosciences against peers on metrics such as P/E, margins, and return on equity helps contextualize its positioning and identify relative strengths or weaknesses.
| Risk & Return | Correlation |
Ideaya Biosciences Market Strength Events
Market strength indicators help investors to evaluate how Ideaya Biosciences stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Ideaya Biosciences shares will generate the highest return on.
Ideaya Biosciences Risk Indicators
The analysis of Ideaya Biosciences' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Ideaya Biosciences' investment and either accepting that risk or mitigating it.
| Mean Deviation | 2.08 | |||
| Standard Deviation | 2.71 | |||
| Variance | 7.33 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Ideaya Biosciences
Coverage intensity for Ideaya Biosciences matters because narrative visibility can influence sentiment, participation, and volatility around the name. The stronger process compares story flow with performance, theme classification, and the level of short-term market interest.
Contributor Headline
Latest Perspective From Macroaxis
Ideaya Biosciences Short Properties
Short sentiment tied to Ideaya Biosciences matters because heavier bearish pressure can change how quickly future price expectations become unstable. Used correctly, these measures can help investors decide when hedging or timing discipline may matter more than conviction alone.
| Common Stock Shares Outstanding | 88.5 M | |
| Cash And Short Term Investments | 639.4 M |
More Resources for Ideaya Stock Analysis
A structured review of Ideaya Biosciences often starts with core financial statements and trend context. Key ratios help frame profitability, efficiency, and growth context for Ideaya Biosciences Stock. Outlined below are key reports that provide context for Ideaya Biosciences Stock:Use Historical Fundamental Analysis of Ideaya Biosciences to cross-verify projections for Ideaya Biosciences. The view provides historical context for the projection set. For information on how to trade Ideaya Stock refer to our How to Trade Ideaya Stock guide.Analysis related to Ideaya Biosciences should be read together with other portfolio and risk tools before capital is reallocated. That is especially important when the goal is to improve the overall mix of instruments already held. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Earnings Share -1.28 | Revenue Per Share | Quarterly Revenue Growth 0.554 | Return On Assets | Return On Equity |
The market value of Ideaya Biosciences is measured differently than book value, which reflects Ideaya accounting equity. Ideaya Biosciences' market capitalization is 2.88 B. A P/B ratio of 2.92 indicates the market values Ideaya Biosciences above its accounting book value. Enterprise value stands at 2.38 B. Intrinsic value represents an estimate of underlying worth and can differ from both market price and book value. Valuation methods compare these perspectives to frame context.
Note that Ideaya Biosciences' intrinsic value and market price are different measures derived from different inputs. For Ideaya Biosciences, key inputs include a P/B ratio of 2.92, a profit margin of -51.99%, ROE of -10.92%, and revenue of 218.71 M. By contrast, market price reflects the level where buyers and sellers transact.